50P Cardiosafe nano-formulation of doxorubicin allows coadministration with trastuzumab in neoadjuvant setting improving antitumor efficacy and preventing trastuzumab-mediated cardiotoxicity in HER2 + murine model of breast cancer
Titel:
50P Cardiosafe nano-formulation of doxorubicin allows coadministration with trastuzumab in neoadjuvant setting improving antitumor efficacy and preventing trastuzumab-mediated cardiotoxicity in HER2 + murine model of breast cancer
Auteur:
Mazzucchelli, S. Andreata, F. Bonizzi, A. Sevieri, M. Truffi, M. Sitia, L. Ottria, R. Silva, F. Zerbi, P.F. Prosperi, D. Corsi, F.